Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
10.46B | 12.49B | 8.70B | 6.83B | 6.80B | Gross Profit |
4.35B | 1.93B | 1.74B | 2.10B | 1.82B | EBIT |
2.61B | 1.11B | 1.24B | 900.00M | 769.80M | EBITDA |
3.67B | 831.80M | 4.14B | 1.46B | 1.91B | Net Income Common Stockholders |
1.71B | -158.00M | 3.03B | 2.28B | 167.90M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.04B | 1.21B | 1.13B | 1.60B | 421.00M | Total Assets |
28.27B | 27.14B | 25.76B | 21.59B | 21.03B | Total Debt |
9.13B | 10.94B | 10.12B | 10.88B | 11.34B | Net Debt |
8.10B | 9.73B | 8.98B | 9.28B | 10.92B | Total Liabilities |
16.47B | 17.91B | 17.64B | 16.38B | 17.28B | Stockholders Equity |
11.05B | 8.58B | 8.08B | 5.21B | 3.75B |
Cash Flow | Free Cash Flow | |||
1.35B | -360.90M | 121.40M | 593.30M | 42.80M | Operating Cash Flow |
3.86B | 1.46B | 1.58B | 1.77B | 1.25B | Investing Cash Flow |
-2.86B | -2.96B | -744.90M | 443.70M | -1.01B | Financing Cash Flow |
-857.60M | 1.35B | -1.38B | -778.70M | -603.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $5.98B | 4.12 | 28.91% | 10.08% | -0.03% | 14.25% | |
77 Outperform | $5.95B | 11.70 | 9.47% | 5.07% | -4.45% | 9.86% | |
72 Outperform | $24.71B | 10.11 | 21.53% | 3.21% | -9.86% | 240.30% | |
68 Neutral | $49.20B | 17.09 | 9.55% | 3.32% | -18.00% | -7.54% | |
63 Neutral | $8.49B | 11.24 | 5.22% | 4.35% | 3.04% | -11.95% | |
54 Neutral | $20.19B | 2,867.59 | 0.47% | ― | 12.40% | -108.27% | |
52 Neutral | $7.25B | 4.30 | 29.79% | ― | -3.22% | 141.11% |